drugset / Trial / NCT06389617

Different Doses of Intravenous Administered Dexamethasone Effecting Brachial Plexus Supraclavicular Block

NCT06389617 ↗

RandomizedSingle-groupDouble-blindSupportive care

Summary

To compare the analgesic properties of ultrasound guided supraclavicular block using ropivacaine 0.5% in arteriovenous fistula creation when used in combination with intravenous administered dexamethasone at 4mg and 8 mg as an adjuvant

Timeline

Start
2024-05-01
Primary completion
2024-11-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Dexamethasone Small molecule 8 mg Intravenous
Comparator Ropivacaine Other / unclassified 0.5 % Other
Comparator Ropivacaine Other / unclassified 20 ml Other